KLKwok-Hung Lai

Kwok-Hung Lai

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kwok-Hung Lai has a total of 115 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Reply to Evrard and colleagues

    by G.-H. Lo, K.-H. Lai

    We would like to thank Drs. Evrard and colleagues for their comments on our article regarding the prevention of gastric variceal bleeding [ 1 ]. Evrard et al. have investigated the role of propranolol in the prevention of gastroesophageal variceal rebleeding [ 2 ]). Enrolled in their study were 41 patients with gastroesophageal variceal rebleeding, but only 10 of them were bleeding from gastric varices. Evrard et al. noted that propranolol was as effective as Histoacryl injection in the prevention of gastroesophageal variceal rebleeding, but propranolol was associated with fewer complications. Owing to the small sample size, it is difficult to draw a definite conclusion that nonselective beta-blockers can be employed to prevent gastric variceal bleeding. The application of propranolol in the prevention of esophageal variceal rebleeding has been well established [ 3 ] [ 4 ]), but no controlled studies have ever been specifically focused on the prevention of rebleeding from gastric varices. Currently, nonselective beta-blockers appear to be promising; however, their role in the prevention of rebleeding from gastric varices awaits further investigation. We agree that the inclusion of nonselective beta-blockers as a treatment modality could be helpful for clinicians when they are presented with patients with contraindications to cyanoacrylate injection and the transjugular intrahepatic portosystemic shunt.

  • Influence of juxtapapillary diverticulum on hepatic clearance in patients after endoscopic sphincterotomy

    by Jeng‐Jie Tzeng, Kwok‐Hung Lai, Nan‐Jing Peng, Gin‐Ho Lo, Chiun‐Ku Lin, Hoi‐Hung Chan, Ping‐I Hsu, Jin‐Shiung Cheng, E‐Ming Wang

    Background and Aim:  The role of juxtapapillary diverticulum ( JPD) in biliary stone formation is controversial. This study was designed to understand the relationship between the size of JPD, hepatic clearance and recurrent bile duct stones in patients after endoscopic sphincterotomy.Methods:  Five hundred and twenty patients with choledocholithiasis who had received endoscopic sphincterotomy were enrolled. They were divided into three groups: group A (n = 268) without diverticula; group B (n = 156) with small diverticula; and group C (n = 96) with large diverticula. All patients were regularly followed with interviews, liver function test and sonogram to detect the recurrent bile duct stones. Quantitative cholescintigraphy was performed in 176 cholecystectomized patients to evaluate the hepatic clearance. Sphincter of Oddi manometry was performed to exclude incomplete sphincterotomy if quantitative cholescintigraphy was abnormal.Results:  After 9–111 months of follow‐up, 76 patients had recurrent bile duct stones. There was a significant higher bile duct stone recurrence in group C than in group A (P < 0.01), but no statistical difference was noted between group B and group A (P = 0.2). Patients with JPD were older than those without (P < 0.05). Of 176 cholecystectomized patients, two were excluded because sphincter of Oddi basal pressure was more than 10 mmHg. In the remaining 174 patients, the E45′ was significantly lower in group C than in group A (41.2% ± 18.6%vs 49.1% ± 14.1%; P < 0.05), and there was no significant difference between group B and group A.Conclusions:  JPD is a predisposing factor of delayed biliary emptying and it increases the chance and incidence of recurrent bile duct stones.


  • Open Access

    Composition of common bile duct stones in Chinese patients during and after endoscopic sphincterotomy

    by Wei-Lun Tsai, Kwok-Hung Lai, Chiun-Ku Lin, Hoi-Hung Chan, Ching-Chu Lo, Ping-I Hsu, Wen-Chi Chen, Jin-Shiung Cheng, Gin-Ho Lo

    AIM: Endoscopic sphincterotomy (ES) is a well-established therapeutic modality for the removal of common bile duct (CBD) stones. After ES there are still around 10% of patients that experience recurrent CBD stones. The aim of this study is to investigate the composition of CBD stones before and after ES and its clinical significance in Chinese patients. METHODS: From January 1996 to December 2003, 735 patients with CBD stones received ES at Kaohsiung Veterans General Hospital and stone specimens from 266 patients were sent for analysis. Seventy-five patients had recurrent CBD stones and stone specimens from 44 patients were sent for analysis. The composition of the stones was analyzed by infrared (IR) spectrometry and they were classified as cholesterol or bilirubinate stones according to the predominant composition. Clinical data were analyzed. RESULTS: In the initial 266 stone samples, 217 (82%) were bilirubinate stones, 42 (16%) were cholesterol stones, 3 were calcium carbonate stones, 4 were mixed cholesterol and bilirubinate stones. Patients with bilirubinate stones were significantly older than patients with cholesterol stones (66 ± 13 years vs 56 ± 17 years, P = 0.001). In the 44 recurrent stone samples, 38 (86%) were bilirubinate stones, 3 (7%) were cholesterol stones, and 3 were mixed cholesterol and bilirubinate stones. In 27 patients, both initial and recurrent stone specimens can be obtained, 23 patients had bilirubinate stones initially and 2 became cholesterol stones in the recurrent attack. In the four patients with initial cholesterol stones, three patients had bilirubinate stones and one patient had a cholesterol stone in the recurrent attack. CONCLUSION: Bilirubinate stone is the predominant composition of initial or recurrent CBD stone in Chinese patients. The composition of CBD stones may be different from initial stones after ES.


    • 1 July 2002
      • Vol. 3  (4) , 83-5

    Sphincter of Oddi and acute pancreatitis: a new treatment option.

    by Kwok-Hung Lai


  • Does a fatty meal improve hepatic clearance in patients after endoscopic sphincterotomy?

    by Kwok-Hung Lai, Nan-Jing Peng, Gin-Ho Lo, Chiun-Ku Lin, Hoi-Hung Chan, Ping-I Hsu, Jin-Shiung Cheng, Ya-Yu Wang


  • Open Access

    Effect of somatostatin on the sphincter of Oddi in patients with acute non-biliary pancreatitis

    by K-H Lai, G-H Lo, J-S Cheng, M-T Fu, E-M Wang, H-H Chan, Y-Y Wang, P-I Hsu, C-K Lin

    BACKGROUND Somatostatin has been used to prevent pancreatitis after endoscopic retrograde cholangiopancreatography but its effect on acute non-biliary pancreatitis is still unclear. AIM The purpose of this study was to evaluate the function of the sphincter of Oddi (SO) and the effect of somatostatin on patients with non-biliary pancreatitis. METHODS Twenty patients (18 males, two females) with acute pancreatitis (alcoholic 18, idiopathic two) received SO manometry within one week after admission. After baseline measurement, a bolus dose of somatostatin (Stilamin, Serono) 250 μg was infused slowly, and SO manometry was repeated after five minutes. Continuous infusion of somatostatin 250 μg/h was given for 12 hours after SO manometry. Serum amylase, lipase, glucose, and C reactive protein (CRP) levels were examined before and after somatostatin infusion. RESULTS SO manometry was unsuccessful in six patients due to contracted sphincter. In the remaining 14 patients, high SO basal pressure (SOBP >40 mm Hg) was found in seven patients. After somatostatin infusion, mean SOBP decreased from 48.8 (29) to 31.9 (22) mm Hg (pDISCUSSION Sphincter of Oddi dysfunction is common in patients with acute non-biliary pancreatitis and in most cases somatostatin can relax the sphincter.


    • 1 November 2001
      • Vol. 64  (11) , 609-14

    Sequential changes of gastric hyperplastic polyps following endoscopic ligation.

    by P I Hsu, K H Lai, G H Lo, C K Lin, C C Lo, E M Wang, Y Y Wang, W L Tsai, C P Lin, H H Tseng, et al.

    Endoscopic ligation has been extensively applied in the management of esophageal and gastric varices with or without bleeding. The varices are automatically eradicated through the use of ligation. However, whether avascular necrosis will occur in a gastrointestinal polyp when the base is ligated remains unclear. The aims of this pilot study were to investigate the sequential changes of gastric hyperplastic polyps following endoscopic detachable snare ligation and to determine the possibility of induction of avascular necrosis in these lesions following ligation. Eleven patients with eighteen gastric hyperplastic polyps were treated with endoscopic detachable-snare ligation. The polyps were observed for 5 minutes and biopsies were then conducted. At 14 days after endoscopic ligation, follow-up endoscopies were performed to assess the outcome of the strangulated polyps. After being strangulated by the detachable snares, a majority of the polyps immediately congested (94%), and then developed cyanotic change (89%) approximately 4 minutes later. Pathological examination revealed severe venous congestion in the lamina propria of the strangulated polyps. On follow-up endoscopy 2 weeks later, all the snares had dropped off, and avascular necrosis occurred in sixteen polyps (89%). All of the polyps with avascular necrosis were detected to have developed cyanotic changes in initial endoscopy. No complications occurred during or following the ligation procedure. Most gastric hyperplastic polyps develop avascular necrosis following ligation by detachable snare. Cyanotic change is an important predictor of the outcomes of the lesions following endoscopic ligation. The application of this ligation technique in treatment of bleeding or non-bleeding gastrointestinal polyps deserves further investigation.


    • 1 June 2001
      • Vol. 64  (6) , 331-6

    Cathepsin E and subtypes of intestinal metaplasia in carcinogenesis of the human stomach.

    by C K Lin, K H Lai, G H Lo, J S Cheng, P I Hsu, K T Mok, H H Tseng

    Cathepsin E is found mainly over the gastric surface and foveolar epithelial cells, and it also is found in the metaplastic pyloric glands and cancer cells. The exact function of cathepsin E in gastric mucosa remains unclear. The colonic type (type III) of intestinal metaplasia (IM) is strongly associated with intestinal-type gastric carcinoma. IM is considered to be a precancerous lesion. The aim of this study was to find out the role of cathepsin E in IM, dysplasia and cancer of stomach. Sixty nine biopsy specimens with IM and dysplasia and 33 gastrectomy specimens with gastric carcinoma were fixed, sectioned and stained with PAS-alcian blue stain, high iron-diamine alcian blue stain to classify IM and immunohistochemical stain to localize cathepsin E. Those patients with dysplastic gastric lesions received regular endoscopic follow-up. Fifteen of 69 patients with gastric dysplasia developed cancer in a median 10.5 months follow-up. Severe dysplasia developed carcinoma significantly higher than mild dysplasia (12/20 vs. 1/25, p < 0.001), and type III intestinal metaplasia seemed to have significantly predilection for severe dysplasia and gastric cancer. Cathepsin E was stained in intestinal metaplasia with dysplastic change in 44/69 specimens (63.8%), and carcinoma in 28/48 (58.3%) specimens, there was no significant difference between intestinal type and diffuse type carcinoma in cathepsin E staining. The positive staining for cathepsin E decreased significantly in severe dysplastic gastric mucosa. Type III IM is commonly associated with severe dysplasia and cancer; it may be a precancerous lesion. The positive staining of cathepsin E decreased with the severity of gastric dysplasia, representing dedifferentiation of the cells.


    • 1 June 2001
      • Vol. 64  (6) , 337-42

    Follow-up of Helicobacter pylori status by using 13C-urea breath test in nonulcer dyspeptic patients after eradication therapy.

    by N J Peng, P I Hsu, S C Lee, H H Tseng, W K Huang, D G Tsay, G H Lo, C K Lin, J S Cheng, K H Lai

    The role of eradication therapy is still controversial in H. pylori-related nonulcer dyspepsia (NUD). The aim of this study was to follow up the H. pylori status after eradication therapy in patients with NUD by using l3C-urea breath test (UBT). Patients with a clinical and endoscopic diagnosis of NUD were included. H. pylori infection was established by endoscopic biopsies and 13C-UBT. Patients with H. pylori infection then received a quadruple therapy with colloidal bismuth subcitrate, metronidazole, tetracycline and lansoprazole. Two months after completion of therapy, endoscopic biopsies and 13C-UBT were performed again to confirm eradication. A follow-up 13C-UBT was carried out again in one year to detect recurrence of H. pylori infection. Eighty-eight of the 148 patients (59.5%) were found to have H. pylori infection by both endoscopic biopsies and 13C-UBT. Anti-H. pylori therapy was given for 55 patients and proved successful in 33 of them two months after the end of therapy. However, recurrence was found one year later in three of these 33 cases, making a recurrence rate of 9.1% (3/33). Three of the 22 cases with unsuccessful eradication were found to have H. pylori eradication at one year by follow-up 13C-UBT. One of the 33 H. pylori-positive patients without anti-H. pylori therapy, who had negative 13C-UBT in one year follow-up, was found taking a high dose and long period of antibiotics. The recurrence rate of H. pylori infection in our study was higher than that in the Western population. Delayed eradication of H. pylori may occur after anti-H. pylori therapy. Spontaneous eradication is rare in patients not receiving anti-H. pylori eradication.